Saturday, November 29, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Palatin Technologies Implements 1for25 Reverse Stock Split

Elaine Mendonca by Elaine Mendonca
February 29, 2024
in Breaking News
0
Sleep
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Palatin Technologies is making a bold move by implementing a 1-for-25 reverse stock split on February 28, 2024. This decision will decrease the number of shares of its common stock outstanding without altering the authorized number of shares. The reverse stock split is set to take effect on August 30, 2022, with the common stock trading on a split-adjusted basis starting on August 31, 2022.

Stockholders who hold shares in book-entry form or through a bank, broker, or other nominee do not need to take any action. Palatin Technologies’ common stock will continue to be traded on the NYSE American Stock Market under the symbol “PTN”.

Palatin Technologies is focused on developing groundbreaking medicines that target specific receptors to address diseases with significant unmet medical needs. The company’s strategy involves forming strategic partnerships with industry leaders to maximize the potential of its products.

For more information about Palatin Technologies, you can visit their website at www.Palatin.com and follow them on Twitter at @PalatinTech.

Palatin Technologies Inc. (PTN) Shows Strong Performance in Stock Market on February 28, 2024

On February 28, 2024, Palatin Technologies Inc. (PTN) showed strong performance in the stock market. According to data from CNN Money, PTN is currently trading in the middle of its 52-week range and above its 200-day simple moving average, indicating positive momentum for the stock. The price of PTN shares increased by $0.35 since the market last closed, representing a significant 9.67% rise. The stock closed at $3.97 on February 28, 2024, but continued to climb in after-hours trading, with an additional increase of $0.63. This strong performance on February 28th suggests that investors have confidence in PTN and its potential for growth. Investors and analysts will be closely monitoring PTN’s performance in the coming days to see if this positive momentum continues. Overall, PTN’s strong performance on February 28, 2024, is a promising sign for the company and its investors.

PTN Stock Performance: Revenue Growth but Mixed Earnings Results on February 28, 2024

On February 28, 2024, PTN stock experienced mixed performance based on financial data provided by CNN Money. The company reported total revenue of $4.85 million for the past year, a significant increase of 230.53% compared to the previous year. However, total revenue for the second quarter was $2.03 million, a slight decrease of 3.41% from the previous quarter.

In terms of net income, PTN reported a net loss of $27.54 million for the past year, an improvement of 23.91% compared to the previous year. However, the net loss for the second quarter was $7.84 million, indicating a decrease of 33.21% from the previous quarter.

Earnings per share (EPS) also showed mixed performance for PTN stock. The EPS for the past year was -$2.53, reflecting an increase of 33.32% compared to the previous year. However, the EPS for the second quarter was -$0.56, showing a decrease of 15.01% from the previous quarter.

Overall, the financial performance of PTN stock on February 28, 2024, was characterized by significant revenue growth over the past year, but a slight decline in revenue and net income from the previous quarter. Investors should closely monitor future financial reports and market trends to assess the long-term prospects of PTN stock.

Tags: PTN
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Mining technology

Webull Corporation to Go Public through SPAC Merger A GameChanging Move in Digital Investing

The Rise of Liquid Staking: How Validator-Specific Tokens Are Reshaping DeFi

Analyst Reiterates Neutral Rating for Perficient with Increased Price Target

Finance_Business (1)

RBC Capital Analyst Affirms Outperform Rating on Archrock and Raises Price Target

Recommended

BigBear.ai Stock

BigBear.ai Shares Experience Extreme Volatility Following Defense Contract News

2 months ago
The Trade Desk Stock

The Trade Desk: Strong Earnings Met With Investor Skepticism

3 weeks ago
Airbus Stock

Airbus Helicopter Division Secures Major Contracts Amid Industry Challenges

2 months ago
Biotechnology Trading online

Lexaria Bioscience Corp Announces Registered Direct Offering to Fuel Scientific Advancements

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Methode Electronics Faces Critical Quarterly Test

Core Molding: Navigating Market Headwinds with Strategic Expansion

Abeona Therapeutics: Analyst Forecast Sparks Investor Optimism

Surgepays Stock: Is a Downturn Inevitable?

Acco Brands Shares Face Significant Downward Pressure

Insider Selling and Market Divisions Challenge D.R. Horton

Trending

Ttec Stock
Analysis

Ttec Shares: Can Expansion Strategy Reverse Declining Fortunes?

by Robert Sasse
November 29, 2025
0

Ttec Holdings Inc. saw its stock price advance by 1.83 percent during yesterday's trading session, closing at...

Seres Therapeutics Stock

Seres Therapeutics Stock Approaches Critical Technical Juncture

November 29, 2025

InfuSystem Shares: Analysts Project Significant Upside Potential

November 29, 2025
Methode Electronics Stock

Methode Electronics Faces Critical Quarterly Test

November 29, 2025
Core Molding Stock

Core Molding: Navigating Market Headwinds with Strategic Expansion

November 29, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Ttec Shares: Can Expansion Strategy Reverse Declining Fortunes?
  • Seres Therapeutics Stock Approaches Critical Technical Juncture
  • InfuSystem Shares: Analysts Project Significant Upside Potential

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com